跳至主要内容
临床试验/KCT0004208
KCT0004208招募中未知

A pilot cohort study of autologous bone marrow derived stem cells and platelet rich plasma therapy after hysteroscopy for severe Asherman’s syndrome

Bundang CHA General Hospital0 个研究点目标入组 35 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20(Year) 至 44(Year)(—)
性别
Female

入选标准

  • 1. Infertility patients diagnosed with severe Ashman's syndrome through hysteroscopic screening despite the treatment of at least 2 cycles of hormone therapy, the patient was found to have a history of rare menstruation or a maximum thickness of less than 6 mm
  • 2. Body mass index <30kg / m2
  • 3. Who wants to get pregnant
  • 4. Those without abnormal findings in preoperative examination
  • 5. The patient decided to participate in the study and both the subject and the spouse signed the agreement

排除标准

  • 1.Hemoglobin < 10.0, Platelet<130,000 or other hematologic diseases
  • 2.Currently suffering from pelvic inflammatory disease
  • 3.Uterine or pelvic conditions required additional treatment for pregnancy (uterine anomaly, submucosal myoma, adenomyosis with an antero-posterior diameter of 7 cm or more, Severe endometriosis stage 3-4)
  • 4.Uncontrolled endocrine or medical illness.
  • 5. A person who has been judged to be inappropriate medically by the clinical trial researcher

研究者

发起方
Bundang CHA General Hospital

相似试验